MR imaging enhancement patterns as predictors of hemorrhagic transformation in acute ischemic stroke

American Journal of Neuroradiology

Volumn 24, Issue 4, 2003, Pages 674-679

  Vo, Katie D ^a   Santiago, Fernando ^b   Lin, Weili ^c   Hsu, Chung Y ^b   Lee, Yueh ^c   Lee, Jin Moo ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM; TISSUE PLASMINOGEN ACTIVATOR;

ACUTE DISEASE; ADULT; AGED; ARTICLE; BRAIN BLOOD VESSEL; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; EVALUATION; FEMALE; FOLLOW UP; HUMAN; IMAGE ANALYSIS; IMAGE ENHANCEMENT; MALE; MENINX; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PARENCHYMA; PETECHIA; PREDICTION; RATING SCALE; RETROSPECTIVE STUDY; SAMPLE; SYMPTOM;

AGED; AGED, 80 AND OVER; BRAIN; CEREBRAL ARTERIES; CEREBRAL HEMORRHAGE; CEREBRAL INFARCTION; DIFFUSION MAGNETIC RESONANCE IMAGING; ECHO-PLANAR IMAGING; FEMALE; HUMANS; IMAGE ENHANCEMENT; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; NEUROLOGIC EXAMINATION; NEUROPROTECTIVE AGENTS; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS; REFERENCE VALUES; RETROSPECTIVE STUDIES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0037395571     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-1587
2. Alberts MJ. tPA in acute ischemic stroke: United States experience and issues for the future. Neurology 1998;51:S53-S55
3. Jaillard A, Cornu C, Durieux A, et al. Hemorrhagic transformation in acute ischemic stroke: The MAST-E study - MAST-E group. Stroke 1999;30:1326-1332
4. Larrue V, von Kummer RR, Muller A, Bluhmki E. Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II). Stroke 2001;32:438-441
5. Bowes MP, Zivin JA, Thomas GR, Thibodeaux H, Fagan SC. Acute hypertension, but not thrombolysis, increases the incidence and severity of hemorrhagic transformation following experimental stroke in rabbits. Exp Neurol 1996;141:40-46
6. Fisher M. Aspirin, anticoagulants, and hemorrhagic conversion of ischemic infarction: hypothesis and implications. Bull Clin Neurosci 1986;51:68-72
7. Okada Y, Yamaguchi T, Minematsu K, et al. Hemorrhagic transformation in cerebral embolism. Stroke 1989;20:598-603
8. Kano T, Katayama Y, Tejima E, Lo EH. Hemorrhagic transformation after fibrinolytic therapy with tissue plasminogen activator in a rat thromboembolic model of stroke. Brain Res 2000;854:245-248
9. Fagan SC, Garcia JH. Hemorrhagic transformation in focal cerebral ischemia: influence of time to artery reopening and tissue plasminogen activator. Pharmacotherapy 1999;19:139-142
10. Molina CA, Montaner J, Abilleira S, et al. Timing of spontaneous recanalization and risk of hemorrhagic transformation in acute cardioembolic stroke. Stroke 2001;32:1079-1084
11. Broderick JP, Hagen T, Brott T, Tomsick T. Hyperglycemia and hemorrhagic transformation of cerebral infarcts. Stroke 1995;26:484-487
12. Vo KD, Lee JM, Kido DK, Littenberg B. Agreement among the experts in interpreting CT scans in stroke patients eligible for iv r-tPA. Paper presented at: Annual Meeting of the Association of University Radiologists; 2001; Toronto, Ontario, Canada.
13. Grotta JC, Chiu D, Lu M, et al. Agreement and variability in the interpretation of early CT changes in stroke patients qualifying for intravenous rtPA therapy. Stroke 1999;30:1528-1533
14. Barber PA, Demchuk AM, Zhang J, Buchan AM. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy: ASPECTS Study Group - Alberta Stroke Programme Early CT Score. Lancet 2000;355:1670-1674
15. Tong DC, Adami A, Moseley ME, Marks MP. Relationship between apparent diffusion coefficient and subsequent hemorrhagic transformation following acute ischemic stroke. Stroke 2000;31:2378-2384
16. Tong DC, Adami A, Moseley ME, Marks MP. Prediction of hemorrhagic transformation following acute stroke: role of diffusion- and perfusion-weighted magnetic resonance imaging. Arch Neurol 2001;58:587-593
17. Selim M, Fink JN, Kumar S, et al. Predictors of hemorrhagic transformation after intravenous recombinant tissue plasminogen activator: prognostic value of the initial apparent diffusion coefficient and diffusion-weighted lesion volume. Stroke 2002;33:2047-2052
18. Kidwell CS, Saver JL, Villablanca JP, et al. Magnetic resonance imaging detection of microbleeds before thrombolysis: an emerging application. Stroke 2002;33:95-98
19. Nighoghossian N, Hermier M, Adeleine P, et al. Old microbleeds are a potential risk factor for cerebral bleeding after ischemic stroke: a gradient-echo T2*-weighted brain MRI study. Stroke 2002;33:735-742
20. Knight RA, Barker PB, Fagan SC, Li Y, Jacobs MA, Welch KM. Prediction of impending hemorrhagic transformation in ischemic stroke using magnetic resonance imaging in rats. Stroke 1998;29:144-151
21. Dijkhuizen RM, Asahi M, Wu O, Rosen BR, Lo EH. Delayed rt-PA treatment in a rat embolic stroke model: diagnosis and prognosis of ischemic injury and hemorrhagic transformation with magnetic resonance imaging. J Cereb Blood Flow Metab 2001;21:964-971
22. Neumann-Haefelin C, Brinker G, Uhlenkuken U, Pillekamp F, Hossmann KA, Hoehn M. Prediction of hemorrhagic transformation after thrombolytic therapy of clot embolism: an MRI Investigation in rat brain. Stroke 2002;33:1392-1398
23. Yokogami K, Nakano S, Ohta H, Goya T, Wakisaka S. Prediction of hemorrhagic complications after thrombolytic therapy for middle cerebral artery occlusion: value of pre- and post-therapeutic computed tomographic findings and angiographic occlusive site. Neurosurgery 1996;39:1102-1107
24. Koenigsberg RA, Gul N, Faro S, Elfont R, Baker K, Tsai F. Hyperacute cerebral enhancement: the earliest predictor of hemorrhage by MR imaging? J Neuroimaging 1999;9:235-236
25. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. Stroke 1997;28:2109-2118
26. Mayer TE, Schulte-Altedorneburg G, Droste DW, Bruckmann H. Serial CT and MRI of ischaemic cerebral infarcts: frequency and clinical impact of haemorrhagic transformation. Neuroradiology 2000;42:233-239
27. Yenari MA, Beaulieu C, Steinberg GK, Moseley ME. Diffusion-weighted magnetic resonance imaging characteristics of hemorrhagic transformation in experimental embolic stroke. J Neuroimaging 1997;7:227-231
28. Elster AD, Moody DM. Early cerebral infarction: gadopentetate dimeglumine enhancement. Radiology 1990;177:627-632
29. Hamann GF, del Zoppo GJ, von Kummer R. Hemorrhagic transformation of cerebral infarction-possible mechanisms. Thromb Haemost 1999;82(Suppl 1):92-94
30. Sumii T, Lo EH. Involvement of matrix metalloproteinase in thrombolysis-associated hemorrhagic transformation after embolic focal ischemia in rats. Stroke 2002;33:831-836
31. Roberts HC, Dillon WP, Furlan AJ, et al. Computed tomographic findings in patients undergoing intra-arterial thrombolysis for acute ischemic stroke due to middle cerebral artery occlusion: results from the PROACT II trial. Stroke 2002;33:1557-1565
32. Kilpatrick MM, Yonas H, Goldstein S, et al. CT-based assessment of acute stroke: CT, CT angiography, and xenon-enhanced CT cerebral blood flow. Stroke 2001;32:2543-2549
33. Ueda T, Sakaki S, Yuh WT, Nochide I, Ohta S. Outcome in acute stroke with successful intra-arterial thrombolysis and predictive value of initial single-photon emission-computed tomography. J Cereb Blood Flow Metab 1999;19:99-108